eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

Review: Xalatan and Alphagan P





Summary: drug interactions are reported among people who take Xalatan and Alphagan P together.

This review analyzes the effectiveness and drug interactions between Xalatan and Alphagan P. It is created by eHealthMe based on reports of 1,348 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone: join a mobile support group for people who take Xalatan and Alphagan P >>>

What are the drugs

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. (latest outcomes from Xalatan 14,567 users)

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. (latest outcomes from Alphagan p 518 users)

On Dec, 4, 2014: 1,348 people who take Xalatan, Alphagan P are studied

Xalatan, Alphagan P outcomes

Drug combinations in study:
- Xalatan (latanoprost)
- Alphagan P (brimonidine tartrate)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Xalatan is effectiven/a50.00%
(1 of 2 people)
n/a0.00%
(0 of 2 people)
0.00%
(0 of 4 people)
20.00%
(1 of 5 people)
0.00%
(0 of 2 people)
n/a
Alphagan P is effective0.00%
(0 of 2 people)
0.00%
(0 of 2 people)
100.00%
(1 of 1 people)
0.00%
(0 of 3 people)
0.00%
(0 of 2 people)
0.00%
(0 of 2 people)
0.00%
(0 of 3 people)
n/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Eye IrritationPyrexiaTinnitusCorneal ThinningOcular HyperaemiaCataractNauseaIntraocular Pressure Increased
GlaucomaPancytopeniaDyspnoeaNasal CongestionDepressionIntraocular Pressure IncreasedMuscular WeaknessGlaucoma
Drug IneffectiveBone Marrow FailureNasal CongestionIntraocular Pressure IncreasedEye OedemaDrug IneffectiveAstheniaVisual Acuity Reduced
Dry EyeInflammationCoughMacular OedemaEye PruritusFatigueTinnitusDyspnoea
Superficial Injury Of EyeCoughAbnormal DreamsDyspnoeaRashVisual DisturbanceEyelid Margin CrustingDrug Ineffective
Sensation Of Foreign BodyAbnormal DreamsUrinary Tract MalformationVisual Acuity ReducedAmnesiaBlood Pressure IncreasedFatigue
Eyelid OedemaHypersensitivityGrowth Of EyelashesCoughDrug HypersensitivityDrug HypersensitivityEye Irritation
Eye PainNasal CongestionPainMental DisorderEye IrritationDry EyePain
HypersensitivityTinnitusDizzinessVisual ImpairmentTinnitusSomnolenceDizziness
Blindness TransientVisual Acuity ReducedAtrial FibrillationPainJoint StiffnessPolyneuropathyAsthenia

Drug effectiveness by gender :

FemaleMale
Xalatan is effective22.22%
(2 of 9 people)
0.00%
(0 of 6 people)
Alphagan P is effective12.50%
(1 of 8 people)
0.00%
(0 of 7 people)

Most common drug interactions by gender * :

FemaleMale
Intraocular Pressure IncreasedIntraocular Pressure Increased
Visual Acuity ReducedGlaucoma
DyspnoeaVisual Acuity Reduced
FatigueEye Irritation
Drug IneffectiveDrug Ineffective
PainDyspnoea
AstheniaOcular Hyperaemia
ConstipationCardiac Failure Congestive
GlaucomaDizziness
NauseaCondition Aggravated

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Xalatan is effectiven/an/an/an/a100.00%
(1 of 1 people)
33.33%
(1 of 3 people)
0.00%
(0 of 7 people)
0.00%
(0 of 20 people)
Alphagan P is effectiven/an/a0.00%
(0 of 1 people)
n/a0.00%
(0 of 1 people)
33.33%
(1 of 3 people)
0.00%
(0 of 7 people)
0.00%
(0 of 19 people)

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
Pupillary Reflex Impairedn/aHaemoglobin DecreasedDrug IneffectiveDrug IneffectiveIntraocular Pressure IncreasedDyspnoeaIntraocular Pressure Increased
Neutrophil Percentage DecreasedImmunodeficiencyVitreous HaemorrhageVisual Field DefectVisual Acuity ReducedGlaucomaVisual Acuity Reduced
Neonatal TachypnoeaCoombs Test PositiveIntraocular Pressure IncreasedScotomaEye IrritationPainFatigue
Neonatal HypotensionAntibody Test AbnormalCorneal OedemaCorneal OedemaDrug IneffectiveVisual Acuity ReducedDrug Ineffective
Urine Output DecreasedGlaucoma AggravatedVision BlurredHeadache NosIntestinal ObstructionNauseaAsthenia
White Blood Cell Count IncreasedDyspnoeaHerpes Simplex OphthalmicWhite Blood Cell Count IncreasedPneumoniaVision Blurred
HypothermiaBlood Pressure DecreasedVisual Acuity ReducedBlindness UnilateralVomitingEye Irritation
HypotensionFeeling AbnormalIntraocular Pressure IncreasedPartial SeizuresAnaemiaPyrexia
Bradycardia NosRetinal TearDisease ProgressionVitreous HaemorrhageFatigueDizziness
ApnoeaVisual Acuity ReducedBack PainDrug Withdrawal SyndromeAbdominal Pain UpperGlaucoma

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Xalatan and Alphagan P?

You are not alone! Join a related mobile support group:
- support group for people who take Xalatan and Alphagan P
- support group for people who take Alphagan P
- support group for people who take Xalatan

Can you answer these questions (Ask a question):

More questions for: Alphagan P, Xalatan

More reviews for: Alphagan P, Xalatan

Comments from related studies:

  • From this study (11 months ago):

  • My mom takes all three medications. Is this combination good? and does this cause her eyelids and lashes to form the crust?

    Reply

  • From this study (12 months ago):

  • Bp has gone up to 142/71. Pulse is between 66 & 76. This has occurred since I started taking Meloxicam.

    Reply

  • From this study (3 years ago):

  • I have developed tinnitus, hearing loss, neck pain, weakness, fatigue, cold sweats, fainting symptoms, loosing balance, swollen ankles, headaches

    Reply

Post a new comment    OR    Read more comments

Complete drug side effects:

On eHealthMe, Xalatan (latanoprost) is often used to treat glaucoma. Alphagan P (brimonidine tartrate) is often used to treat glaucoma. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.